Forward Pharma A/S (NASDAQ:FWP) Rating Lowered to Strong Sell at ValuEngine

ValuEngine downgraded shares of Forward Pharma A/S (NASDAQ:FWP) from a sell rating to a strong sell rating in a research report sent to investors on Wednesday, June 26th, ValuEngine reports.

FWP stock traded up $0.01 during trading hours on Wednesday, reaching $0.95. 1,224 shares of the stock were exchanged, compared to its average volume of 12,301. The firm’s 50-day simple moving average is $0.97. Forward Pharma A/S has a 12 month low of $0.71 and a 12 month high of $3.44.

About Forward Pharma A/S

Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Read More: What is the strike price in options trading?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Forward Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forward Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.